Pentamidine Is Active In Vitro againstFusariumSpecies
Open Access
- 1 October 2003
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (10) , 3252-3259
- https://doi.org/10.1128/aac.47.10.3252-3259.2003
Abstract
Fusariosis is an emerging opportunistic mycosis against which currently used antifungals have limited activity. Here, we investigated the in vitro activities of pentamidine (PNT) against 10 clinical isolates of Fusarium species (five Fusarium solani isolates and five non-F. solani isolates) by using the National Committee for Clinical Laboratory Standards microdilution method in three different media (RPMI, RPMI-2, and a yeast nitrogen base medium), disk diffusion testing, and viability dye staining. PNT had significant activities against all 10 Fusarium isolates. Non-F. solani isolates were more susceptible than F. solani isolates (P < 0.05). Additionally, PNT was fungicidal against all non-F. solani isolates, whereas it had fungistatic effects against four of the five F. solani isolates. PNT also exhibited greater activity against conidial than against hyphal development of the fungus. This fungicidal activity against non-F. solani Fusarium isolates was confirmed microscopically after staining of PNT-treated Fusarium oxysporum hyphae with the fluorescent viability dyes 5,(6)-carboxyfluorescein diacetate (CFDA) and bis-(1,3-dibutylbarbituric acid) trimethine oxonol (DiBAC). The MICs at which 50% of the isolates were inhibited (2 μg/ml for non-F. solani isolates and 4 μg/ml for F. solani isolates) and the minimum fungicidal concentration at which 50% of the isolates were killed (8 μg/ml for non-F. solani isolates) were much lower than the PNT tissue concentrations previously reported in humans using conventional daily intravenous PNT dosing. Finally, PNT was more active against Fusarium isolates in a hypoxic environment of in vitro growth (P < 0.05). This finding may be clinically significant, because Fusarium, an angiotropic mold, causes tissue infarcts with resultant low tissue perfusion. Our findings suggest that PNT may have a role in the management of Fusarium infections. Future in vivo studies are needed to verify these in vitro findings.Keywords
This publication has 29 references indexed in Scilit:
- In Vitro Synergistic Interaction between Amphotericin B and Pentamidine against Scedosporium prolificansAntimicrobial Agents and Chemotherapy, 2002
- In Vitro Activities of Investigational Triazoles againstFusariumSpecies: Effects of Inoculum Size and Incubation Time on Broth Microdilution Susceptibility Test ResultsAntimicrobial Agents and Chemotherapy, 2002
- The Antifungal Echinocandin Caspofungin Acetate Kills Growing Cells of Aspergillus fumigatus In VitroAntimicrobial Agents and Chemotherapy, 2002
- Testing Conditions for Determination of Minimum Fungicidal Concentrations of New and Established Antifungal Agents for Aspergillus spp.: NCCLS Collaborative StudyJournal of Clinical Microbiology, 2002
- In Vitro Activities of Pentamidine, Pyrimethamine, Trimethoprim, and Sulfonamides against Aspergillus SpeciesAntimicrobial Agents and Chemotherapy, 2002
- Colorimetric Assay for Antifungal Susceptibility Testing of Aspergillus SpeciesJournal of Clinical Microbiology, 2001
- Analysis of Growth Characteristics of Filamentous Fungi in Different Nutrient MediaJournal of Clinical Microbiology, 2001
- Experimental pathogenicity of four opportunist Fusarium species in a murine modelJournal of Medical Microbiology, 1999
- Use of a New Bioassay to Study Pentamidine PharmacokineticsThe Journal of Infectious Diseases, 1985
- Mechanism of antimicrobial action of metronidazoleJournal of Antimicrobial Chemotherapy, 1979